Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline (2020)
- Authors:
- USP affiliated authors: LOTUFO, LETICIA VERAS COSTA - ICB ; PESSOA JUNIOR, ADALBERTO - FCF ; LOPES, LUCIANA BIAGINI - ICB ; MIGUEL, RODRIGO DOS ANJOS - ICB ; APOLINÁRIO, ALEXSANDRA CONCEIÇÃO - ICB ; HIRATA, AMANDA SOARES - ICB
- Unidades: ICB; FCF
- DOI: 10.2217/nnm-2020-0290
- Subjects: FARMACOLOGIA; NEOPLASIAS MAMÁRIAS; NANOTECNOLOGIA; ANTINEOPLÁSICOS; QUIMIOTERÁPICOS; MELANOMA; FARMACOS; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Nanomedicine
- ISSN: 1743-5989
- Volume/Número/Paginação/Ano: v. 15, n. 26, p. 2539–2542
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
APOLINÁRIO, Alexsandra Conceição et al. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, v. 15, n. 26, p. 2539–2542, 2020Tradução . . Disponível em: https://doi.org/10.2217/nnm-2020-0290. Acesso em: 11 jun. 2024. -
APA
Apolinário, A. C., Hirata, A. S., Miguel, R. dos A., Lotufo, L. V. C., Pessoa Junior, A., Clair, J. J. L., et al. (2020). Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline. Nanomedicine, 15( 26), 2539–2542. doi:10.2217/nnm-2020-0290 -
NLM
Apolinário AC, Hirata AS, Miguel R dos A, Lotufo LVC, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 jun. 11 ] Available from: https://doi.org/10.2217/nnm-2020-0290 -
Vancouver
Apolinário AC, Hirata AS, Miguel R dos A, Lotufo LVC, Pessoa Junior A, Clair JJL, Fenical W, Lopes LB. Exploring the benefits of nanotechnology for cancer drugs in different stages of the drug development pipeline [Internet]. Nanomedicine. 2020 ; 15( 26): 2539–2542.[citado 2024 jun. 11 ] Available from: https://doi.org/10.2217/nnm-2020-0290 - Beyond formulation: contributions of nanotechnology for translation of anticancer natural products into new drugs
- Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase
- Preclinical development of seriniquinones as selective dermcidin modulators for the treatment of melanoma
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
- Lipid nanovesicles for biomedical applications: ‘what is in a name’?
- Towards nanoformulations for skin delivery of poorly soluble API: What does indeed matter?
- Co-encapsulation of paclitaxel and C6 ceramide in tributyrin-containing nanocarriers improve co-localization in the skin and potentiate cytotoxic effects in 2D and 3D models
- Multifunctional nanoemulsions promote cutaneous co-localization of chemotherapeutic agents and improve efficacy in 3D models of skin cancer
- Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment
Informações sobre o DOI: 10.2217/nnm-2020-0290 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
